Cost-Utility Analysis of Treatment Algorithms for Moderate Grade Vesicoureteral Reflux Using Markov Models

Journal of Urology

Volumn 177, Issue 2, 2007, Pages 703-709

  Hsieh, Michael H ^a   Swana, Hubert S ^a   Baskin, Laurence S ^a   Meng, Maxwell V ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

cost benefit analysis; decision making; dextranomer hyaluronic acid copolymer; Markov chains; vesico ureteral reflux

Indexed keywords

COPOLYMER; DEXTRANOMER; HYALURONIC ACID;

ALGORITHM; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; DISEASE SEVERITY; ENDOSCOPIC THERAPY; FOLLOW UP; HUMAN; IMAGING; MEDICAL DECISION MAKING; MORBIDITY; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROBABILITY; PYELONEPHRITIS; SENSITIVITY ANALYSIS; STATISTICAL MODEL; SURGICAL APPROACH; TREATMENT PLANNING; VESICOURETERAL REFLUX;

ALGORITHMS; CHILD, PRESCHOOL; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; INFANT; MALE; MARKOV CHAINS; SEVERITY OF ILLNESS INDEX; VESICO-URETERAL REFLUX;

EID: 33846000319     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2006.10.002     Document Type: Article

References (20)

1. Freedman A.L. Urologic Diseases in North America Project: trends in resource utilization for urinary tract infections in children. J Urol 173 (2005) 949
2. Smellie J.M., and Normand I.C. Clinical features and significance of urinary tract infection in children. Proc R Soc Med 59 (1966) 415
3. Elder J.S., Diaz M., Caldamone A.A., Cendron M., Greenfield S., Hurwitz R., et al. Endoscopic therapy for vesicoureteral reflux: a meta-analysis. I. Reflux resolution and urinary tract infection. J Urol 175 (2006) 716
4. Elder J.S., Peters C.A., Arant Jr. B.S., Ewalt D.H., Hawtrey C.E., Hurwitz R.S., et al. Pediatric Vesicoureteral Reflux Guidelines Panel summary report on the management of primary vesicoureteral reflux in children. J Urol 157 (1997) 1846
5. Garin E.H., Olavarria F., GarciaNieto V., Valenciano B., Campos A., and Young L. Clinical significance of primary vesicoureteral reflux and urinary antibiotic prophylaxis after acute pyelonephritis: a multicenter, randomized, controlled study. Pediatrics 117 (2006) 626
6. Mathews R., Naslund M., and Docimo S. Cost analysis of the treatment of vesicoureteral reflux: a computer model. J Urol 163 (2000) 561
7. Kobelt G., Canning D.A., Hensle T.W., and Lackgren G. The cost-effectiveness of endoscopic injection of dextranomer/hyaluronic acid copolymer for vesicoureteral reflux. J Urol 169 (2003) 1480
8. Thompson M., Simon S.D., Sharma V., and Alon U.S. Timing of follow-up voiding cystourethrogram in children with primary vesicoureteral reflux: development and application of a clinical algorithm. Pediatrics 115 (2005) 426
9. Kirsch A.J., Perez-Brayfield M., Smith E.A., and Scherz H.C. The modified STING procedure to correct vesicoureteral reflux: improved results with submucosal implantation within the intramural ureter. J Urol 171 (2004) 2413
10. Puri P., Chertin B., Velayudham M., Dass L., and Colhoun E. Treatment of vesicoureteral reflux by endoscopic injection of dextranomer/hyaluronic acid copolymer: preliminary results. J Urol 170 (2003) 1541
11. Hitt E. Novel algorithm helps identify treatment for VUR. Urol Times 33 (2005) 16
12. Capozza N., Lais A., Matarazzo E., Nappo S., Patricolo M., and Caione P. Treatment of vesico-ureteric reflux: a new algorithm based on parental preference. BJU Int 92 (2003) 285
13. Ogan K., Pohl H.G., Carlson D., Belman A.B., and Rushton H.G. Parental preferences in the management of vesicoureteral reflux. J Urol 166 (2001) 240
14. Kirsch A.J., Perez-Brayfield M.R., and Scherz H.C. Minimally invasive treatment of vesicoureteral reflux with endoscopic injection of dextranomer/hyaluronic acid copolymer: the Children's Hospitals of Atlanta experience. J Urol 170 (2003) 211
15. Brouwer W.B., Niessen L.W., Postma M.J., and Rutten F.F. Need for differential discounting of costs and health effects in cost effectiveness analyses. BMJ 331 (2005) 446
16. Wheeler D., Vimalachandra D., Hodson E.M., Roy L.P., Smith G., and Craig J.C. Antibiotics and surgery for vesicoureteric reflux: a meta-analysis of randomised controlled trials. Arch Dis Child 88 (2003) 688
17. Gold M.R., Siegel J.E., Russell L.B., and Weinstein M.C. Cost-Effectiveness in Health and Medicine (1996), Oxford University Press, New York
18. Hensle T.W., Hyun G., Grogg A., and Eaddy M. Examining pediatric vesicoureteral reflux: a real-world evaluation of treatment patterns and outcomes. J Urol 175 suppl (2006) 247 abstract 761
19. Papadopoulou F., Efremidis S.C., Oiconomou A., Badouraki M., Panteleli M., Papachristou F., et al. Cyclic voiding cystourethrography: is vesicoureteral reflux missed with standard voiding cystourethrography?. Eur Radiol 12 (2002) 666
20. Capozza N., Lais A., Nappo S., and Caione P. The role of endoscopic treatment of vesicoureteral reflux: a 17-year experience. J Urol 172 (2004) 1626